Mapping and targeting of the leukemic microenvironment

被引:35
作者
Witkowski, Matthew T. [1 ,2 ]
Kousteni, Stavroula [3 ]
Aifantis, Iannis [1 ,2 ]
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA
[2] NYU, Laura & Isaac Perlmutter Canc Ctr, Dept Pathol, New York, NY 10003 USA
[3] Columbia Univ, Dept Physiol & Cellular Biophys, Irving Med Ctr, New York, NY USA
基金
美国国家卫生研究院;
关键词
HEMATOPOIETIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; BONE-MARROW ADIPOCYTES; MESENCHYMAL STROMAL CELLS; T-CELLS; GENE-EXPRESSION; IN-VIVO; FUNCTIONAL INHIBITION; DISEASE EVOLUTION;
D O I
10.1084/jem.20190589
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous studies support a role of the microenvironment in maintenance of the leukemic clone, as well as in treatment resistance. It is clear that disruption of the normal bone marrow microenvironment is sufficient to promote leukemic transformation and survival in both a cell autonomous and non-cell autonomous manner. In this review, we provide a snapshot of the various cell types shown to contribute to the leukemic microenvironment as well as treatment resistance. Several of these studies suggest that leukemic blasts occupy specific cellular and biochemical "niches." Effective dissection of critical leukemic niche components using single-cell approaches has allowed a more precise and extensive characterization of complexity that underpins both the healthy and malignant bone marrow microenvironment. Knowledge gained from these observations can have an important impact in the development of microenvironment-directed targeted approaches aimed at mitigating disease relapse.
引用
收藏
页数:13
相关论文
共 146 条
[31]   Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment [J].
Dong, Lei ;
Yu, Wen-Mei ;
Zheng, Hong ;
Loh, Mignon L. ;
Bunting, Silvia T. ;
Pauly, Melinda ;
Huang, Gang ;
Zhou, Muxiang ;
Broxmeyer, Hal E. ;
Scadden, David T. ;
Qu, Cheng-Kui .
NATURE, 2016, 539 (7628) :304-+
[32]   Leukemia Propagating Cells Rebuild an Evolving Niche in Response to Therapy [J].
Duan, Cai-Wen ;
Shi, Jun ;
Chen, Jing ;
Wang, Bo ;
Yu, Ye-Hua ;
Qin, Xia ;
Zhou, Xiang-Cheng ;
Cai, Yi-Jun ;
Li, Zuo-Qing ;
Zhang, Fang ;
Yin, Min-Zhi ;
Tao, Ying ;
Mi, Jian-Qing ;
Li, Lin-Heng ;
Enver, Tariq ;
Chen, Guo-Qiang ;
Hong, Deng-Li .
CANCER CELL, 2014, 25 (06) :778-793
[33]   Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML [J].
Duarte, Delfim ;
Hawkins, Edwin D. ;
Akinduro, Olufolake ;
Ang, Heather ;
De Filippo, Katia ;
Kong, Isabella Y. ;
Haltalli, Myriam ;
Ruivo, Nicola ;
Straszkowski, Lenny ;
Vervoort, Stephin J. ;
McLean, Catriona ;
Weber, Tom S. ;
Khorshed, Reema ;
Pirillo, Chiara ;
Wei, Andrew ;
Ramasamy, Saravana K. ;
Kusumbe, Anjali P. ;
Duffy, Ken ;
Adams, Ralf H. ;
Purton, Louise E. ;
Carlin, Leo M. ;
Lo Celso, Cristina .
CELL STEM CELL, 2018, 22 (01) :64-+
[34]   Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL [J].
Duell, J. ;
Dittrich, M. ;
Bedke, T. ;
Mueller, T. ;
Eisele, F. ;
Rosenwald, A. ;
Rasche, L. ;
Hartmann, E. ;
Dandekar, T. ;
Einsele, H. ;
Topp, M. S. .
LEUKEMIA, 2017, 31 (10) :2181-2190
[35]   CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells [J].
Edwards, David K., V ;
Watanabe-Smith, Kevin ;
Rofelty, Angela ;
Damnernsawad, Alisa ;
Laderas, Ted ;
Lamble, Adam ;
Lind, Evan F. ;
Kaempf, Andy ;
Mori, Motomi ;
Rosenberg, Mara ;
d'Almeida, Amanda ;
Long, Nicola ;
Agarwal, Anupriya ;
Sweeney, David Tyler ;
Loriaux, Marc ;
McWeeney, Shannon K. ;
Tyner, Jeffrey W. .
BLOOD, 2019, 133 (06) :588-599
[36]   Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine [J].
Ehsanipour, Ehsan A. ;
Sheng, Xia ;
Behan, James W. ;
Wang, Xingchao ;
Butturini, Anna ;
Avramis, Vassilios I. ;
Mittelman, Steven D. .
CANCER RESEARCH, 2013, 73 (10) :2998-3006
[37]   Low turnover bone disease in Egyptian children with acute leukemia [J].
El-Ziny, MA ;
Al-Tonbary, YA ;
Salama, OS ;
Bakr, AA ;
Al-Marsafawy, H ;
Elsharkawy, AA .
HEMATOLOGY, 2005, 10 (04) :327-333
[38]   CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia [J].
Fedorchenko, Oleg ;
Stiefelhagen, Marius ;
Peer-Zada, Abdul A. ;
Barthel, Romy ;
Mayer, Petra ;
Eckei, Laura ;
Breuer, Alexandra ;
Crispatzu, Giuliano ;
Rosen, Natascha ;
Landwehr, Thomas ;
Lilienthal, Nils ;
Moellmann, Michael ;
Montesinos-Rongen, Manuel ;
Heukamp, Lukas ;
Duerig, Jan ;
Hallek, Michael ;
Fingerle-Rowson, Guenter ;
Herling, Marco .
BLOOD, 2013, 121 (20) :4126-4136
[39]   Long-term imatinib therapy promotes bone formation in CML patients [J].
Fitter, Stephen ;
Dewar, Andrea L. ;
Kostakis, Panagiota ;
To, L. Bik ;
Hughes, Timothy P. ;
Roberts, Marion M. ;
Lynch, Kevin ;
Vernon-Roberts, Barrie ;
Zannettino, Andrew C. W. .
BLOOD, 2008, 111 (05) :2538-2547
[40]   Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression [J].
Fleming, Viktor ;
Hu, Xiaoying ;
Weber, Rebekka ;
Nagibin, Vasyl ;
Groth, Christopher ;
Altevogt, Peter ;
Utikal, Jochen ;
Umansky, Viktor .
FRONTIERS IN IMMUNOLOGY, 2018, 9